Laurent Fraisse

Sanofi Aventis R&D
Toulouse, 31036, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction: Facing the escalating burden of dengue: Challenges and perspectives.

Correction: Facing the escalating burden of dengue: Challenges and perspectives.

Journal: PLOS global public health

Published: July 09, 2024

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.

Journal: Heliyon

Published: January 09, 2024

Facing the escalating burden of dengue: Challenges and perspectives.

Facing the escalating burden of dengue: Challenges and perspectives.

Journal: PLOS global public health

Published: December 15, 2023

Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.

Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.

Journal: Antiviral research

Published: November 28, 2023

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Journal: Science (New York, N.Y.)

Published: November 09, 2023

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens.

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens.

Journal: iScience

Published: August 23, 2023

Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice.

Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2023

Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin.

Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin.

Journal: Angewandte Chemie (International ed. in English)

Published: July 21, 2022

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.

Journal: Microorganisms

Published: July 07, 2022

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions.

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions.

Journal: ACS infectious diseases

Published: February 22, 2022

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.

Journal: EBioMedicine

Published: December 17, 2021

Towards the sustainable discovery and development of new antibiotics.

Towards the sustainable discovery and development of new antibiotics.

Journal: Nature reviews. Chemistry

Published: July 01, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026